Genomic Medicine Sweden
Genomic Medicine Sweden, GMS, is paving the way for improved diagnostics, care and treatment.
News
GMS and Hartwig Foundation sign agreement to advance precision medicine for cancer patients
On 1 June 2026, Genomic Medicine Sweden (GMS) and the Hartwig Medical Foundation (Hartwig) signed a Memorandum of Understanding (MoU) to accelerate precision oncology for cancer patients in Sweden, the Netherlands, and beyond. The agreement establishes a strategic...
Strong physician interest in genetic testing – but knowledge gaps are slowing progress
Genomic analyses, including studies of the entire genome, are being used increasingly in healthcare, but knowledge and preparedness are not keeping pace. A study involving more than 100 physicians from different specialties shows that only a minority feel sufficiently...
Global commission to pave the way for equal precision health
A new Lancet Commission on Precision Health has been launched to develop a comprehensive framework for integrating precision approaches into health systems worldwide. Researchers from Karolinska Institutet, Lund university and Genomic Medicine Sweden are contributing...
Sweden’s ambitious national collaboration for genomic medicine
Our strategic mission is to foster collaboration between healthcare providers, academia, patient organizations and industry and realize precision medicine by effectively utilizing the rapidly advancing sequencing technologies to provide the highest standards of genomic testing in routine clinical care throughout Sweden.
Healthcare
A close collaboration between healthcare and academia is central in introducing new forms of diagnostics as the basis for an individualized choice of treatment.
Patients & next of kin
Participation and knowledge from patients and next of kin representatives is crucial for GMS to be able to introduce precision medicine in health care based on the individual’s needs.
Industry
Through an active collaboration with industry, GMS will develop and provide tomorrow´s solutions for the diagnostics and treatment of various diseases.
Academia
GMS forms a strong basis for researchers to better understand why disease arises and how new forms of treatment can be developed.
Regional centers
Seven regional centers are the GMS engine
GMS is comprised of seven regional Genomic Medicine Centers (GMC). These joint centers act as the primary point of contact for sequencing patient samples within healthcare, thereby creating an integrated platform for both healthcare delivery and advanced medical research. Each GMC is a collaboration between a region with university hospital care, a university with a faculty of medicine, and SciLifeLab.
Participating partners
In collaboration with
